Year 2023 / Volume 115 / Number 5
Original
Relationship between DHX15 expression and survival in colorectal cancer

234-240

DOI: 10.17235/reed.2022.8838/2022

Leqi Fan, Xiangyu Guo, Jiyi Zhang, Yuji Wang, Jinhui Wang, Ye Li,

Abstract
Objective: to explore the relationship between the expression of DEAH-box RNA helicase 15 (DHX15) in colorectal cancer (CRC), its clinical pathological features and survival. Method: DHX15 expression data with clinical pathological features from the Cancer Gene Atlas (TCGA) and the Clinical Proteomic Tumor Analysis Consortium (CPTAC) were statistically analyzed for the association between DHX15 expression and overall survival in CRC. The expression of DHX15 was performed by immunohistochemical staining (IHC) using tumor and the adjacent normal tissue, mounted in tissue microarrays. The significance of DHX15 expression to predict survival and prognosis of CRC were analyzed using the Kaplan-Meier method, univariate and multivariate Cox regression analysis. Results: low expression of DHX15 mRNA and DHX15 protein in CRC were both negative factors for survival. Overall survival of patients with low-expression of DHX15 was significantly lower (χ2 = 8.452, p = 0.004) by Kaplan-Meier evaluation. Low expression of DHX15 in CRC tissues correlated with distal lymph node metastasis (χ² = 7.120, p = 0.008), TNM stage (χ² = 3.935, p = 0.047) and disease recurrence (χ² = 9.524, p = 0.002) in CRC. Low expression of DHX15 (HR = 4.012, 95 % CI: 1.462-11.013, p = 0.007), late TNM stage (HR = 0.067, 95 % CI: 0.029-0.156, p < 0.001) and recurrence (HR = 0.008, 95 % CI: 0.002-0.034, p < 0.001) were risk factors related to the prognosis of CRC patients by univariate Cox regression analysis. Conclusion: our findings reveal a key role for DHX15 in the progress of CRC metastasis and recurrence. DHX15 may be a potential biomarker for CRC targeted therapy.
Lay Summary
We explored the relationship between the expression of DEAH-box RNA helicase 15 (DHX15) and survival prognosis in colorectal cancer (CRC). Clinical pathological features, survival and the expression of DHX15 of CRC samples were obtained from the Cancer Gene Atlas (TCGA) and the Clinical Proteomic Tumor Analysis Consortium (CPTAC) databases, and subjected to statistical analysis. Furthermore, the expression of DHX15 in both tumor and the adjacent normal tissue of CRC patients was performed by immunohistochemical staining (IHC) mounted in tissue microarrays. As the result, low expression of DHX15 mRNA and DHX15 protein in CRC samples were both poor prognostic factors for CRC survival, metastasis and recurrence.
Share Button
New comment
Comments
No comments for this article
References
1. Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin, 2021, 71(3): 209-249.
2. Pellino G, Gallo G, Pallante P, et al. Noninvasive Biomarkers of Colorectal Cancer: Role in Diagnosis and Personalised Treatment Perspectives. Gastroenterol Res Pract, 2018, 2018: 2397863.
3. Studer Michael K, Ivanović Lazar, Weber Marco E, et al. Structural basis for DEAH-helicase activation by G-patch proteins. Proc Natl Acad Sci U S A, 2020, 117(13): 7159-7170.
4. Ribera J, Portolés I, Córdoba-Jover B, et al. The loss of DHX15 impairs endothelial energy metabolism, lymphatic drainage and tumor metastasis in mice. Commun Biol, 2021, 4(1): 1192.
5. Detanico T, Virgen-Slane R, Steen-Fuentes S, et al. Co-expression Networks Identify DHX15 RNA Helicase as a B Cell Regulatory Factor. Front Immunol, 2019, 10: 2903.
6. Mosallanejad K, Sekine Y, Ishikura-Kinoshita S, et al. The DEAH-box RNA helicase DHX15 activates NF-κB and MAPK signaling downstream of MAVS during antiviral responses. Sci Signal, 2014, 7(323): ra40.
7. Xing J, Zhou X, Fang M, et al. DHX15 is required to control RNA virus-induced intestinal inflammation. Cell Rep, 2021, 35(12): 109205.
8. Wang Y, He K, Sheng B, et al. The RNA helicase Dhx15 mediates Wnt-induced antimicrobial protein expression in Paneth cells. Proc Natl Acad Sci U S A, 2021, 118(4): e2017432118
9. Pan L, Li Y, Zhang HY, et al. DHX15 is associated with poor prognosis in acute myeloid leukemia (AML) and regulates cell apoptosis via the NF-kB signaling pathway. Oncotarget, 2017, 8(52): 89643-89654.
10. Yao G, Chen K, Qin Y, et al. Long Non-coding RNA JHDM1D-AS1 Interacts with DHX15 Protein to Enhance Non-Small-Cell Lung Cancer Growth and Metastasis. Mol Ther Nucleic Acids, 2019, 18(): 831-840.
11. Jing Y, Nguyen MM, Wang D, et al. DHX15 promotes prostate cancer progression by stimulating Siah2-mediated ubiquitination of androgen receptor. Oncogene, 2018, 37(5): 638-650.
12. Ito S, Koso H, Sakamoto K, Watanabe S. RNA helicase DHX15 acts as a tumour suppressor in glioma. Br J Cancer, 2017, 117(9): 1349-1359.
13. Zhao M, Ying L, Wang R, et al. DHX15 Inhibits Autophagy and the Proliferation of Hepatoma Cells. Front Med (Lausanne), 2021, 7(): 591736.
14. Zong Z, Li H, Ning Z, et al. Integrative bioinformatics analysis of prognostic alternative splicing signatures in gastric cancer. J Gastrointest Oncol, 2020, 11(4): 685-694.
15. Kim Jaeho, Lee Heung Kyu. Potential Role of the Gut Microbiome in Colorectal Cancer Progression. Front Immunol, 2021, 12: 807648.
16. Hibino Sana, Kawazoe Tetsuro, Kasahara Hidenori, et al. Inflammation-Induced Tumorigenesis and Metastasis. Int J Mol Sci, 2021, 22(11).
Related articles

Letter

Vaginal lesion as first manifestation of colorectal disease

DOI: 10.17235/reed.2022.9270/2022

Review

Inflammatory bowel disease and solid organ transplantation

DOI: 10.17235/reed.2020.7361/2020

Original

Can we optimize CEA as a response marker in rectal cancer?

DOI: 10.17235/reed.2020.7321/2020

Review

New non-invasive biomarkers for colorectal cancer screening

DOI: 10.17235/reed.2020.7233/2020

Letter

Medullary colorectal carcinoma. Do we really know it?

DOI: 10.17235/reed.2020.6728/2019

Letter

The rectosigmoid junction: are limits important?

DOI: 10.17235/reed.2019.5983/2018

Editorial

Colorectal cancer screening and survival

DOI: 10.17235/reed.2018.5870/2018

Editorial

The right colon challenge

DOI: 10.17235/reed.2018.5544/2018

Letter to the Editor

Neuroendocrine tumors of the pancreas: keys issues in dealing with heterogeneity

DOI: 10.17235/reed.2017.4997/2017

Letter to the Editor

Pancreatic neuroendocrine tumors. Prognostic factors

DOI: 10.17235/reed.2017.5109/2017

Editorial

Pancreas neuroendocrine tumors - not so rare or benign

DOI: 10.17235/reed.2016.4672/2016

Letter to the Editor

Liver metastasis from colorectal cancer 12 years after liver transplantation

DOI: 10.17235/reed.2017.4507/2016

Review

Serrated lesions and serrated polyposis syndrome

DOI: 10.17235/reed.2017.4065/2015

Letter to the Editor

Endobronchial metastases of colorectal cancer

DOI: 10.17235/reed.2016.4080/2015

Citation tools
Fan L, Guo X, Zhang J, Wang Y, Wang J, Li Y, et all. Relationship between DHX15 expression and survival in colorectal cancer. 8838/2022


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 977 visits.
This article has been downloaded 112 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 05/04/2022

Accepted: 19/09/2022

Online First: 30/09/2022

Published: 05/05/2023

Article revision time: 136 days

Article Online First time: 178 days

Article editing time: 395 days


Share
This article hasn't been rated yet.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology